RAISE trial
Marinus Pharmaceuticals Slashes 45% of Workforce Following Disappointing Phase 3 Trial Results
Marinus Pharmaceuticals, staff layoffs, phase 3 trials, ganaxolone, refractory status epilepticus, RAISE trial, TrustTSC trial
Actionable Insights Powered by AI
Marinus Pharmaceuticals, staff layoffs, phase 3 trials, ganaxolone, refractory status epilepticus, RAISE trial, TrustTSC trial